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Background: Electroacupuncture (EA) pretreatment can induce the tolerance against focal cerebral ischemia.
However, the underlying mechanisms have not been fully understood. Emerging evidences suggest that canonical
Notch signaling may be involved in ischemic brain injury. In the present study, we tested the hypothesis that EA
pretreatment-induced tolerance against focal cerebral ischemia is mediated by Notch signaling.
Results: EA pretreatment significantly enhanced Notch1, Notch4 and Jag1 gene transcriptions in the striatum,
except Notch1 intracellular domain level, which could be increased evidently by ischemia. After ischemia and
reperfusion, Hes1 mRNA and Notch1 intracellular domain level in ischemic striatum in EA pretreatment group were
increased and reached the peak at 2 h and 24 h, respectively, which were both earlier than the peak achieved in
control group. Intraventricular injection with the γ-secretase inhibitor MW167 attenuated the neuroprotective effect
of EA pretreatment.
Conclusions: EA pretreatment induces the tolerance against focal cerebral ischemia through activation of canonical
Notch pathway.
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Notch is a cell-surface receptor. Binding of Notch to its
ligands, such as Jagged and Delta-like, results in two-step
proteolytic cleavages of Notch receptor. The second
cleavage accomplished by presenilin-1 and γ-secretase
enzyme complex releases Notch intracellular domain
(NICD) that translocates to the nucleus where it regu-
lates transcription of the Notch target genes, such as Hes
family. This process is the canonical Notch signaling
[1,2]. NICD can also induce the expression of Hes genes
through the activation of cytoplasmic signals [3]. Trad-
itionally, Notch signaling is implicated in neural devel-
opment, including the maintenance of self-renewal
potential in stem cells, binary cell-fate determination in
progenitor cells and induction of terminal differentiation* Correspondence: houlihong@fmmu.edu.cn; csyicu@126.com
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reproduction in any medium, provided the orin proliferating cells [1,2,4]. Accumulating evidence indi-
cates that canonical Notch pathway can also be activated
in the adult brain subjected to stroke and traumatic brain
injury [5-7]. This activation is vital in the regulation of
ischemic cerebral damage, adult neurogenesis and regen-
erative responses after ischemia and reperfusion. How-
ever, it is still controversial whether the activated
canonical Notch signaling is beneficial to the ischemic
cerebral tissues.
Our previous studies have demonstrated that pretreat-
ment with electroacupuncture (EA) at Baihui acupoint
could induce two phases of tolerance to focal cerebral
ischemia, a rapid tolerance occurred at 2 h after EA and
a delayed tolerance occurred at 24 h after EA [8,9].
We further elucidate the adenosine, endocannabinoid
and cannabinoid receptor type 1(CB1) are involved in
the mechanism underlying rapid ischemic tolerance
[8,10], while cannabinoid receptor 2 (CB2) is responsible
for the induction of delayed tolerance [11]. Identifying
the signals that mediate the neuroprotection of EAtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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targets. Thus, we hypothesized that Notch signaling
is involved in the EA pretreatment-induced tolerance
against focal cerebral ischemia. The present study was
designed to testify this hypothesis in the rat subjected
focal cerebral ischemia.
Results
EA pretreatment significantly increased Notch1, Notch4
and Jag1 mRNA in the striatum before ischemia
Real-time RT-PCR analysis for Notch1, Notch4, Jag1 and
Hes1 genes, which are major Notch pathway components
in the central nervous system, in striatum and hippocam-
pus before MCAO showed that the Notch1, Notch4 and
Jag1 mRNA in striatum in EA group was up-regulated
compared with CON group. However, the Hes1 mRNA
was not changed (Figure 1A). There were no significant
differences between EA and CON groups in the mRNA
level of the above genes in hippocampus (Figure 1B).
EA pretreatment significantly enhanced Notch1 NICD
level and Hes1 mRNA in the striatum at the early stage
of reperfusion
Real-time RT-PCR analysis for Hes1 gene in striatum
after MCAO (Figure 2A) showed that in EA group, Hes1
mRNA rapidly increased to the maximum at 2 h after
reperfusion (P < 0.05 vs. before I/R), and then gradually
returned to the its pre-brain ischemia level. The con-
tent of Hes1 mRNA in EA group was significantly higher
than that in CON group at 2 h and 24 h after reper-
fusion, respectively (P < 0.05 vs. CON). The variation
pattern of Hes1 mRNA was different in CON group.
Although Hes1 mRNA level was increased at 2 h, the
peak appeared at 72 h after reperfusion (P < 0.05 vs.
before I/R).
NICD is regarded as another activation marker of
Notch signaling. There are four Notch receptors in the
central nervous system. Notch1 represents a major func-
tion of Notch pathway in the brain. Thus, we measured
Notch1 NICD level to further evaluate the activation pat-
tern of Notch signaling. Western blot analysis of striatumFigure 1 The bar graph shows quantification of the real-time PCR ana
significantly up-regulated the Notch1, Notch4 and Jag1 mRNA expressions
mRNA expressions of Notch1, Notch4, Jag1 and Hes1 among three groupsrevealed that no significant difference in Notch1 NICD
level was detected between EA and CON groups before
the MCAO (P= 0.37). In EA group, Notch1 NICD level
was significantly elevated 2 h after reperfusion (P < 0.05,
vs. before I/R) and reached the maximum at 24 h
(P < 0.05 vs. before I/R). The NICD level of EA group was
significantly higher than CON group at 2 h and 24 h
(P < 0.05 vs. CON). The Notch1 NICD of EA group at
72 h after reperfusion decreased to a level equal to that
before I/R and was lower than that in CON group at the
same time point. In CON group, ischemia/reperfusion
itself also significantly increased Notch1 NICD level at
24 h after reperfusion (P < 0.05 vs. before I/R). The
Notch1 NICD level was further increased at 72 h
(P < 0.05 vs. before I/R) after reperfusion (Figure 2B and
Figure 2C).
As shown in Figure 3A, there were few Notch1
NICD positive cells in Sham group, while Notch1 NICD
positive cells were increased in CON and EA groups
(Figure 3D and Figure 3G). Double immunofluorescent
staining showed that NICD immunoreactivity was par-
tially localized to the nuclei of cells that were also posi-
tive for NeuN, a neuronal marker, in the ischemic
striatum at 24 h after reperfusion (Figure 3F and
Figure 3I). The quantitation result revealed that there
were more Notch1 NICD positive cells in EA group than
CON group, and the number of cells positive for both
NICD and NEUN in EA group was also much more than
that in CON group(P < 0.05, EA vs. CON)(Figure 3J and
Figure 3L)Intraventricular injections with the γ-secretase inhibitor
MW167 attenuated the neuroprotective effect of EA
pretreatment
We investigated the efficacy of MW167 in suppressing
activation of Notch in the brain in vivo by measuring the
level of Notch1 NICD in ischemic striatum. Western blot
analysis of EA+MW167 and EA groups confirmed that
1 mM MW167 effectively inhibited Notch signal activa-
tion at 24 h after reperfusion (Figure 4).lysis in the striatum and hippocampus (n = 3). (A) EA pretreatment
in striatum before MCAO. (B) There were no significant differences of
in hippocampus before MCAO. (*P< 0.05 EA vs. CON).
Figure 2 The quantification analysis of Hes1 mRNA and Notch1
NICD protein. (A) The quantification of the real-time PCR analysis of
Hes1 mRNA in the striatum of rat brain compared with GAPDH
respectively in CON and EA Before I/R (lane 1, 2), CON and EA I/R2h
(lane 3, 4), CON and EA I/R24h (lane 5, 6), CON and EA I/R72h (lane
7, 8) groups. (B) Representative Western blot bands of Notch1 NICD
(80 kDa) expression obtained from rats in CON and EA Before I/R
(lane 1, 2), CON and EA I/R2h (lane 3, 4), CON and EA I/R24h (lane 5,
6), CON and EA I/R72h (lane 7, 8) groups. (C) The bar graph shows
quantification of the Western blot analysis for the Notch1 NICD
protein compared with β-actin. Pretreatment with EA significantly
up-regulated the Hes1 mRNA and Notch1 NICD protein expressions
at 2 and 24 h after the end of ischemia/reperfusion. While the
expressions of Hes1 mRNA and Notch1 NICD protein of EA group
were down-regulated at 72 h compared to CON group (*P< 0.05 vs.
CON of the same time point, # P< 0.05 vs. before I/R of the same
group).
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measuring the infarct volumes (n = 8). EA pretreatment
remarkably improved functional outcome as indicated
by the significantly higher neurological function score
[13.0(8–15) vs. 6.0(4–9), 72 h] and reduced infarct volumecompared with CON group (19.1 ± 2.1% vs. 49.7 ± 2.2%)
(P < 0.05, EA vs. CON). The infarct volume in EA+
MW167 group was significantly larger than that in EA
group (46.8 ± 4.6% vs. 19.1 ± 2.1%), and the neurological
function score was significantly lower than that in EA
group [6.0(4–9) vs. 13.0(8–15), 72 h](P < 0.05, EA+
MW167 vs. EA). There were no statistical significance
in the neurological function score and infarct volume
between EA+DMSO and EA groups (P= 1.00; P= 0.98)
or CON and EA+MW167 groups (P= 0.83; P= 0.58).
Treatment with MW167 in MCAO only animals also
resulted in reduced brain damage, which manifested as
higher neurological function score and decreased infarct
volume compared with CON group (*P < 0.05, MW167
vs. CON), but the cerebral injury of MW167 group was
more severe than that of EA and EA+DMSO groups
(#P < 0.05, MW167 vs. EA, MW167 vs. EA+DMSO)
(Figure 5).Discussion and conclusions
Our findings provide the first evidence that activation of
Notch signaling contributes to EA pretreatment-induced
cerebral ischemic tolerance. EA pretreatment before is-
chemia significantly increased Notch1,Notch4 receptors
and Jag1 ligand mRNA in the striatum of adult rats and
did not affect the Notch1 NICD and Hes1 mRNA levels,
suggesting no activation of Notch pathway. However,
after ischemia/reperfusion, Hes1 mRNA and Notch1
NICD protein level in EA group reached the peak at 2 h
and 24 h, respectively, while both of them reached the
peak at 72 h in CON group. The earlier activation of
Notch signal may be caused by the higher expression of
Notch1, Notch4 and Jag1 before ischemia in the EA pre-
treatment group. Although EA pretreatment can not in-
crease the activation of Notch pathway before ischemia/
reperfusion, it prepared the essential materials for the
following Notch pathway activation after ischemia/
reperfusion. Intraventricular injections with MW167 can
block the cleavage of all four Notch receptors and lead
to inactivation of Notch pathway in the central nervous
system [12]. The γ-secretase inhibitors may prove to be
more superior agents than that target a single cell type,
because they may target pathogenic events in multiple
cell types (neurons, lymphocytes and microglia) involved
in cerebral ischemic injury. Our current data demon-
strated that the neuroprotective effect of EA precondi-
tioning was abrogated in the presence of intraventricular
injections with MW167, suggesting that γ-secretase-
mediated Notch signaling is required for the cerebral
ischemic tolerance induced by EA pretreatment. Thus,
the activated Notch signaling at the early stage after
reperfusion is beneficial to the survival of neurons in the
ischemic cerebral tissues.
Figure 3 Up-regulation of neuronal Notch1 NICD in the rat brain at 24 h after EA pretreatment. (A–I) Representative double
immunofluorescence staining of Notch1 NICD cells (red) and the neuronal marker (green) NeuN (neurons) in brain sections were displayed.
The Notch1 NICD immunoreactivities are increased and colocalized with the neuronal immunoreactivities 24 h after EA pretreatment. Scale
bars = 20 μm. Figures J and L show quantitative data of NICD- positive and NICD/NEUN double-positive cell numbers every field in the ipsilateral
striatum (n = 3) . The rectangle in K (bregma, 0.2 mm) shows the precise region of the rat brain where these images were taken. (*P< 0.05 EA
vs. CON).
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part in the cellular differentiation of the developing
central nervous system (CNS) have been proved, the
functions of the signaling pathway, especially under
pathological conditions in the adult CNS, remain to be
illuminated. A line of data indicates that the expressions
of notch receptors were up-regulated after MCAO in
the brain of rat. [5,7,13]. The same phenomenon was
observed in our study which demonstrated that focalcerebral ischemia/reperfusion can enhance Hes1 mRNA
and Notch1 NICD protein level in striatum of adult rat.
However, different to our results, Kawai et al. found that
the mRNA of Hes5, an important downstream gene of
Notch signal, was decreased on days 1 and 3 after global
ischemia in rats, suggesting that the Notch signaling
may be inhibited after transient forebrain ischemia [14].
The differences in animal strain, stroke model or treat-
ment regimen may account for the discrepancy. So the
Figure 4 MW167 decreases the expression of Notch1 NICD in the striatum at 24 h after I/R. (A) Representative Western blot bands of
Notch1 NICD (80 kDa) expression obtained from rats in EA (lane 1), EA +MW167 (lane 2) groups. (B) The bar graph shows quantification of the
Western blot analysis for the Notch1 NICD protein compared with β-actin. (*P< 0.05 EA vs. EA +MW167).
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Notch pathway in the CNS has been widely accepted.
In this study, we found that intraventricular injections
with the γ-secretase inhibitor MW167 without EA pre-
treatment could reduce brain damage and ameliorated
functional outcome in a rat model of stroke, suggesting
that the inhibition of Notch signaling activation after
ischemia/reperfusion could lessen the cerebral injury. In
accordance with our results, it has been reported that
Notch signaling increase the vulnerability of neurons to
apoptosis. And γ-secretase inhibition improves func-
tional outcome and reduces brain damage in ischemic
stroke in mice by activating microglial cells and facilitat-
ing the infiltration of proinflammatory leukocytes [5].
However, some results support the idea that the activa-
tion of Notch pathway exerts the neuroprotective effect
after ischemia. Gastric lavage with soybean isoflavone
decreased the ischemia-induced apoptosis in the cerebral
cortex and this effect of soybean isoflavone was asso-
ciated with activation of the Notch signaling in the cere-
bral cortex [15]. Notch receptor activation inhibits cell
death in neural stem cells in vitro rapidly, and this
survival effect of Notch ligands was antagonized by a
γ-secretase inhibitor. A more delayed activation of NotchFigure 5 Neurological scores (A) and infarct volumes (B, C) at 72 h af
improved the neurological scores and reduced the infarct volume while th
pretreatment. Treatment with MW167 in MCAO only animals also inducedsignaling, which was induced by infusing the Notch lig-
and Dll4 into the cerebral lateral ventricle of adult rats,
had no effect on improving cerebral infarct size but
improved the motor skills over a period of 45 days [3].
A possible explanation for these apparently contradicting
results is the different time frame. Our data showed that
the earlier activation of Notch signal after ischemia/
reperfusion induced by EA pretreatment provided pro-
tective effects.
However, our results raise the issue of why the earlier
activation of Notch signaling induced by EA can change
its characteristic from possible damaging effect to pro-
tective effect. The cerebral infarction induced by MCAO
in rats and mice can be thought as a sphere in which
cells in the inner core die rapidly by necrosis, in minutes
to a few hours. However the cells in the outer “penum-
bral regions” die slowly, in a period of days to weeks. The
evidence that neurons in the cerebral ischemic penumbra
undergo apoptosis was first provided by Linnik and cow-
orkers [16]. Whether or not a neuron survives when
exposed to potentially lethal injury is likely to depend
upon which of the antiapoptotic and proapoptotic path-
ways prevails. Studies of stroke in animal models sup-
port the hypothesis that the brain activates antiapoptoticter reperfusion in the rats. Pretreatment with EA significantly
e γ-secretase inhibitor MW167 abolished the protective effect of EA
neuroprotective effect. (*P< 0.05 vs. CON; #P< 0.05 vs. MW167).
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cytokines as responds to ischemic insults. The ischemia-
related insults induce the rapid increased expression of
several neurotrophic factors and cytokines in the rodent
brain, leading to activation of signaling pathways that
result in suppressing oxygen radical production and sta-
bilizating cellular calcium homeostasis [17,18]. The effect
of Notch pathway depends on the integration with other
cellular signals, the degree of Notch activation, and the
time point when the Notch pathway is activated during
the cell cycle in development [19]. Earlier activation of
Notch signaling in the striatum induced by EA pretreat-
ment probably enhanced more survival signals. Later
activation of Notch pathway resulted from ischemia/
reperfusion in CON induced more neurodegenerative
pathways.
Previous in vitro studies suggest that the cleavage of
Notch activates the survival cascade downstream of the
insulin receptor involving the serine/threonine kinase
Akt and mammalian target of rapamycin, and that
Ser727 phosphorylation of STAT3 also mediates the
survival effects induced by Notch activation in neural
stem cells [3]. There is a crucial physiologically crosstalk
between the two major signal transduction pathways —
Notch–Hes and JAK–STAT in the central nervous
system [20]. It is demonstrated that the neuroprotective
effect of EA pretreatment may be relevant to activation
of PI3K/Akt and JAK/STAT signals [21,22]. These results
imply that the activation of Notch signaling may link the
EA pretreatment with some survival signal transducers.
Notch pathway is also a useful paradigm to demon-
strate the complexity of cross-talk pathway with nuclear
factor-kB, transforming growth factor-β and Wnt signal-
ings in ischemia/reperfusion [23,24].
In conclusion, the current study provides novel insights
into the neuroprotection induced by EA pretreatment:
EA preconditioning induces neuroprotection by control-
ling the timing of Notch pathway activation. However,
further studies are demanded to delineate the down-
stream factors of Notch signaling for understanding the




The experimental protocols were approved by the Ethics
Committee for Animal Experimentation and were per-
formed according to the Guidelines for Animal Experi-
mentation of the Fourth Military Medical University.
The animals were provided by the Experimental Animal
Center of the Fourth Military Medical University. Adult
male Sprague–Dawley (SD) rats weighing 280–320 g
were housed under controlled condition with a 12 h
light/dark cycle, temperature at 21°C ± 2°C, and humidityin 60%-70%. The rats were allowed to freely access to
standard rodent diet and tap water.
Experimental protocols
Eighteen male SD rats were randomly divided into 3
groups(n = 6 each): Sham, CON, EA group. Sham and
CON groups received 40 mg/kg SP for 5 days, while EA
group received both 40 mg/kg SP and 30 min EA stimuli
for 5 days. At 24 h after the last EA pretreatment (red
arrow), the rats (n = 3) from 3 groups were killed for real-
time RT-PCR analysis for Notch1, Notch4, Jag1 and
Hes1 genes. At 24 h after reperfusion (yellow arrow),
the rats (n = 3) from 3 groups were killed for double
immunofluorescent staining to show the NICD immu-
noreactivity (Figure 6). Forty-eight male SD rats were
randomly divided into 2 groups (n = 24 each): CON, EA
group. At 24 h after the last EA pretreatment and 2 h,
24 h, 72 h after ischemia/reperfusion (red arrow), the rats
(n = 6 for each time point) from 2 groups were anesthe-
tized and killed. RT-PCR and western blot analysis were
performed (Figure 7). Forty-eight male SD rats were ran-
domly divided into 6 groups(n = 8 each): Sham group
(Sham),Control group (CON),Electroacupuncture group
(EA), γ-secretase inhibitor MW167 group (MW167),
EA+MW167 group (EA+MW167),and EA+Vehicle
group (EA+DMSO). Rats in Sham group did not receive
any treatment only given the same surgical procedure
without arterial occlusion. Animals in other 5 groups
were subjected to middle cerebral arterial occlusion
(MCAO). Rats in CON and MW167 groups were
anesthetized and inhaled oxygen for successive 5 days as
the EA group, but received no EA pretreatment. Animals
in the EA,EA+MW167 and EA+DMSO groups received
the same EA pretreatment. Intraventricular injections
were performed in MW167, EA+MW167 and EA+
DMSO groups (Figure 8).
Electroacupuncture pretreatment and transient focal
cerebral ischemia
EA pretreatment and transient focal cerebral ischemia
were performed as described previously [10]. Briefly, rats
were anesthetized with sodium pentobarbital (40 mg/kg,
i.p.) and inhaled oxygen by face mask at a flow rate of
1 L/min. The Baihui acupoint (GV20), which is located
at the intersection of the sagittal midline and the line
linking two ears, was stimulated with the intensity of
1 mA and frequency of 2/15 Hz for 30 min per day for
successive 5 days by using the G6805–2 EA Instrument
(Model No.227033; Qingdao Xinsheng Ltd). A transient
right middle cerebral artery occlusion (MCAO) was
performed at 24 h after the last pretreatment. Reper-
fusion was accomplished by withdrawing the suture after
120-min ischemia. Blood flow through the middle cere-
bral artery was measured by laser Doppler flowmetry
Figure 6 Experimental protocol diagram 1. Eighteen male SD rats were randomly divided into 3 groups(n = 6 each): Sham, CON, EA group. At
24 h after the last EA pretreatment (red arrow), the rats (n = 3) from 3 groups were killed for real-time RT-PCR analysis for Notch1, Notch4, Jag1
and Hes1 genes. At 24 h after reperfusion (yellow arrow), the rats (n = 3) from 3 groups were killed for double immunofluorescent staining to
show the NICD immunoreactivity.
Zhao et al. BMC Neuroscience 2012, 13:111 Page 7 of 9
http://www.biomedcentral.com/1471-2202/13/111(PeriFlux 5000, Perimed AB, Sweden). Rats retaining
>20% of baseline perfusion during ischemia were excluded.
The incision sites were infiltrated with 0.25% bupivacaine
hydrochloride. Temporalis muscle temperature was moni-
tored and maintained at 37.0°C-37.5°C by surface heat-
ing or cooling during surgery until rats recovered from
anesthesia.Intraventricular injections
Intraventricular injections were performed at 30 min
before MCAO. Animals were anesthetized intraperitone-
ally with sodium pentobarbital, then MW167 (Merck)
was injected unilaterally into the right brain lateral
ventricle with a 32-gauge needle attached to a Hamilton
syringe mounted on a stereotactic device (Kopf Instru-
ments, Inc., Tujunga, CA). Stereotactic coordinates were
as follows: A, -0.1, R, 1.5, and H, 3.8 (coordinates corre-
sponding to the right lateral ventricle) [25]. MW167 was
dissolved in PBS with 10% DMSO and used at the con-
centration of 1 mM [12]. Vehicle (10% DMSO + PBS)
was used as a control treatment. The MW167 solution
and the vehicle were injected over 5 min in a volume
of 12 μl.Figure 7 Experimental protocol diagram 2. Forty-eight male SD rats we
24 h after the last EA pretreatment and 2 h, 24 h, 72 h after ischemia/reper
were anesthetized and killed. RT-PCR and Western blot analysis were perfoReal-time PCR
Three rats per group were killed with an overdose i.p.
injection of pentobarbitone (100 mg/kg body weight).
Hippocampus and striatum were harvested and total
RNA was isolated with RNAiso Plus (TaKaRa), according
to a standard protocol. Quantitative reverse transcription
polymerase chain reaction (RT-PCR) was performed with
the SYBR green real-time PCR method on an IQ5 RT-
PCR instrument (BIO-RAD) with 3-stage program param-
eters provided by the manufacturer. Each sample was
tested in triplicate, and samples were obtained from 3
independent experiments that were used for analysis
of relative gene expression data with the 2-ΔΔCT method.
The following primers for RT-PCR were designed by
TaKaRa corporation : Notch1: (Fwd: AAT GGA GGG
AGG TGC GAA G, Rev: ATG GTG TGC TGA GGC
AAG G); Notch4: (Fwd: CCT GGA CAG CAA TGC
CAA GA, Rev: AGT CCA GCC CTC GTT ACA CAC
AC); Jag1: (Fwd: CCA GCG GTC CTA ATG GTG ATG,
Rev: GCT GTG GTT CTG AGC TGC AAA G); Hes1:
(Fwd: TGT CAA CAC GAC ACC GGA CA, Rev: GCC
TCT TCT CCA TGA TAG GCT TTG); GAPDH: (Fwd:
GGC ACA GTC AAG GCT GAG AAT G, Rev: ATG
GTG GTG AAG ACG CCA GTA).re randomly divided into 2 groups (n = 24 each): CON, EA group. At
fusion (red arrow), the rats (n = 6 for each time point) from 2 groups
rmed.
Figure 8 Experimental protocol diagram 3. Forty-eight male SD rats were randomly divided into 6 groups(n = 8 each): Sham, CON, EA,
MW167, EA + MW167 and EA + DMSO group. At 30 min before MCAO(yellow arrow), intraventricular injections were performed. MW167
and DMSO were given respectively. At 24 h, 48 h and 72 h after ischemia/reperfusion (red arrow), neurological function scores were assessed
in the 6 groups respectively. At 72 h after ischemia/reperfusion, all rats were anesthetized and killed, the infarct volumes were measured.
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To test Notch1 NICD level, three rats per group were
killed with an overdose i.p. injection of pentobarbitone
(100 mg/kg body weight). The striatum at bregma −2.0
to 2 mm was removed before MCAO and at 2 h, 24 h,
or 72 h after reperfusion and homogenized with total
protein extraction kit (KeyGEN, Nanjing, China) on ice.
The following primary antibodies were used in this study:
rabbit anti-Notch1 NICD (1:400; Abcam) or mouse anti-
β-actin (1: 1000; Santa Cruz Biotechnology). Secondary
horseradish peroxidase–conjugated goat–anti-rabbit anti-
body for NICD or goat–anti-mouse antibody for β-actin
(Pierce Biotechnology Inc; 1:5000 dilution) were used.
Quantitative analysis for immunoblotting was performed
after scanning of the X-ray film with a Quantitative-One
software (version 4.60, Bio-Rad, USA). The changes in
relative content of NICD expression were represented as
the ratio of integrated optical density of the band of
NICD to that of β-actin.
Double immunofluorescence staining
At 24 h after reperfusion, three rats from each of the
Sham, CON and EA groups were fixed by transcardial
perfusion with saline followed by perfusion and immer-
sion in 4% paraformaldehyde. A series of adjacent cor-
onal 10 μm-thick sections were cut from the blocks
(bregma A=−2.0-2.0 mm). NICD/NeuN double immuno-
fluorescence analyses were performed. A monoclonal
antibody against NeuN (1:1000, Millipore) and a polyclonalantibody against Notch1 NICD (1:400, Abcam) were
used. Fluorescein isothiocyanate (FITC, Calbiochem) and
cyanine-5.18 (CY5, Jackson Immunoresearch) were used
for double-label immunostaining.
The total numbers of NICD- and NeuN-positive cells
in five separate fields of each section from the ipsilateral
striatum were counted with use of a microscope (Olym-
pus, BX51, Japan) (40×). The values were averaged and
expressed as mean number of NICD- and NeuN-positive
cells per field in striatum.
Neurobehavioral evaluation and infarct assessment
At 24, 48, 72 h after reperfusion, an 18-point scoring sys-
tem reported by Garcia et al. [26] with modifications was
used for neurological assessment by a blinded observer.
Then, rats (n = 8 for each group) were decapitated and
2-mm thick coronal sections throughout the brain
were stained with 2% 2,3,5-triphenyltetrazolium chlo-
ride (Sigma-Aldrich) to evaluate the infarct volume, as
described previously [10].
Statistical analysis
Brain sections were examined by two independent
and blinded investigators. The software, SPSS 11.0 for
Windows (SPSS Inc., Chicago, IL), was used to conduct
statistical analyses. All values, except for neurological
function scores, are presented as mean ± SD. The infarct
volumes, Notch1 NICD level and Notch1, Notch4, Jag1
and Hes1 mRNA level were analyzed by one-way analysis
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http://www.biomedcentral.com/1471-2202/13/111of variance, and differences between-groups were detected
with post hoc Student–Newman–Keuls test. The neuro-
logical function scores were expressed as median (range)
and were analyzed with Kruskal–Wallis test followed by
Mann–Whitney U test with Bonferroni correction. Values
of P<0.05 were considered as statistically significant.
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